For what it's worth, this isn't new, just a new investment. There are a ton of companies in the cell-free biopsy space for early cancer detections, with the big

For what it's worth, this isn't new, just a new investment. There are a ton of companies in the cell-free biopsy space for early cancer detections, with the biggest name being Grail. We're more or less in the engineering/process improvement stage of early cancer detection, not the pure research stage.